Cupid Limited Announces Development of Nitrile Female Condom Targeting Global Monopoly Segment and Strategic Branding Alignment: “Made in India” with “Japanese Quality”

Mumbai (Maharashtra) [India], March 18: Cupid Limited (BSE: 530843 | NSE: CUPID), Cupid Limited, India’s leading manufacturer and exporter of male and female condoms, today announced the commencement of its development programme for a Nitrile (NBR) Female Condom, aimed at entering and diversifying the currently single supplier global nitrile female condom market. The Company also announced a strategic branding alignment centered on the proposition “Made in India” with “Japanese Quality,” reinforcing its commitment to combining India’s strong manufacturing capabilities with globally recognized standards of precision, reliability, and product excellence.

Addressing a Long-Standing Single-Supplier Market

The global female condom market was estimated to be valued at approximately USD 770 million in 2024 and is projected to exceed USD 1.2 billion by 2030. Within this market, the nitrile female condom segment, a premium latex-free category, has historically been supplied by only one manufacturer worldwide, which produces the FC2 Female Condom. With the increasing demand from global procurement agencies for supply diversification, Cupid’s entry into nitrile female condom manufacturing represents a significant strategic opportunity.

Purpose-Built Dual-Polymer Manufacturing Facility

Cupid’s new manufacturing facility, part of the Company’s previously announced expansion programme, has been architecturally and technically designed to accommodate dual-polymer dipping lines operating concurrently. This configuration allows the facility to manufacture:

  • Natural Rubber Latex (NRL) condoms
  • Nitrile Butadiene Rubber (NBR) condoms

on dedicated production lines within the same facility, ensuring no cross-contamination and optimal production efficiency. With this development, Cupid becomes the only condom manufacturer in India with integrated dual-polymer dipping capability, enabling the Company to serve:

  • the established NRL male condom market
  • the NRL female condom market
  • the premium nitrile female condom segment

Upon full commissioning, the expanded new facility is expected to support annual production capacity of approximately:

  • 1.25 billion male condoms
  • 125 million female condoms

Development Programme and Technical Approach

Cupid has initiated a structured research and development programme for the nitrile female condom, supported by international technical expertise with deep domain experience in:

  • NBR compound formulation
  • dipping technology
  • female condom design engineering

The programme will focus on formulation optimization, coagulant engineering, dipping parameters, and comprehensive validation testing, in accordance with ISO 25841:2017 standards for female condoms.

Cupid already possesses a strong regulatory foundation in the segment, with its NRL-based female condom currently holding WHO/UNFPA prequalification and being supplied to more than 50 countries globally.

Strategic Rationale

Cupid’s entry into the nitrile female condom segment is driven by several compelling strategic factors:

1. Supply Diversification

Global procurement agencies such as UNFPA and national ministries of health have long sought alternative suppliers to reduce reliance on a single manufacturer.

2. Premium Product Segment

Nitrile female condoms typically command 25–35% higher prices than latex alternatives due to their key advantages:

  • Latex-free material (suitable for latex-allergic users)
  • Thinner construction
  • Lower odor profile
  • More natural heat conduction

3. Technical and Regulatory Barrier to Entry

The specialized raw material supply chain, formulation expertise, and regulatory requirements create significant barriers to entry. Cupid’s existing technical capabilities and global distribution experience provide a strong platform to compete effectively in this segment.

Commenting on the Development, Mr. Durgesh Garg, Chief Operating Officer said, “For over two decades, the nitrile female condom segment has largely been served by a single supplier. This has limited procurement flexibility for global health agencies and restricted access to latex-free protection for many women worldwide. Cupid is uniquely positioned to address this gap.

Our new manufacturing plant has been purpose-designed from the ground up to support simultaneous dipping of two distinct polymer systems Natural Rubber Latex and Nitrile. This dual-polymer capability will allow us to offer global procurers a credible, quality-assured second source for nitrile female condoms.”

Additionally, Cupid Limited has also announced a strategic branding alignment centered on the powerful proposition “Made in India” with “Japanese Quality.”

This initiative reflects Cupid Limited’s commitment of combining India’s strong manufacturing capabilities with globally recognized standards of precision, reliability, and product excellence. The initiative has been made possible through a collaboration with Asia’s oldest latex condom manufacturing company, further strengthening Cupid’s technological capabilities and reinforcing its global positioning.

The new branding focus is designed to resonate strongly with both Indian consumers and the Company’s valued corporate OEM (Original Equipment Manufacturer) partners worldwide. The initiative also marks a milestone in Cupid Limited’s 28-year journey in condom manufacturing, underscoring the Company’s continued focus on quality, reliability, and innovation.

Through this strategic positioning, Cupid Limited aims to achieve multiple objectives:

For Cupid Brand Consumers
The initiative is intended to strengthen consumer confidence in the Cupid brand, aligning Indian consumers with an elevated standard of trust, safety, and product reliability.

For Corporate OEM Customers
Cupid Limited will extend the same assurance of quality and reliability to its global OEM partners, further reinforcing its position as a dependable and trusted global supplier of high-quality condom products.

With this initiative, Cupid Limited continues to strengthen its position as a trusted global manufacturer delivering world-class quality products, while also highlighting India’s growing role as a reliable manufacturing hub for healthcare and personal wellness products.

Commenting on the Development, Mr. Dhruba Goswami, Business Development Head said, “For over two decades, the nitrile female condom segment has largely been served by a single supplier. This has limited procurement flexibility for global health agencies and restricted access to latex-free protection for many women worldwide. Cupid is uniquely positioned to address this gap.

Our new manufacturing plant has been purpose-designed from the ground up to support simultaneous dipping of two distinct polymer systems Natural Rubber Latex and Nitrile. This dual-polymer capability will allow us to offer global procurers a credible, quality-assured second source for nitrile female condoms.”

Disclaimer: This article is for informational purposes only and does not constitute financial advice.

aayush jain acquisition Business cashew processing cote d’ivoire esos 2026 pacific global fzco Pajson Agro pulkit jain Royal Mewa Share Swap

From Local to Global: Pajson Agro India to Acquire Pacific Global FZCO, Adding 60,000 MT Capacity at the World’s Largest Cashew Origin

All-stock 100% acquisition | ₹354.52 crore | Board also approves ESOS 2026 New Delhi [India], November 6: Pajson Agro India Limited (PAJSON | 544657 | INE14LM01012), a vertically integrated cashew processing company with farm-gate sourcing across key producing origins and a growing consumer brand, ‘Royal Mewa’, has announced that its Board of Directors, has approved […]

Read More
Business Fredun Pharmaceuticals EBITDA Growth Fredun Pharmaceuticals H1 FY27 Results Fredun Pharmaceuticals Net Profit Fredun Pharmaceuticals Revenue Growth Indian pharmaceutical industry

Fredun Pharmaceuticals On A Growth Overdrive: Net Profit Soars 94%, Ebitda Rockets 92% And Revenue Surges 87% In H1 Fy27

Mumbai (Maharashtra) [India], November 6: Fredun Pharmaceuticals Limited (BSE – FREDUN | 539730), one of India’s leading pharmaceutical formulation manufacturing companies, has announced its unaudited financial results for Q2 & H1 FY27. The Company offers a diversified portfolio spanning generics, cosmeceuticals, nutraceuticals, mobility solutions, and animal healthcare products. Key Financial Highlights Standalone key Financial Highlights […]

Read More
Business

Patil Automation Marks a Strong First Half of FY27; Consolidated Revenue Up 37% YoY, Net Profit Up 48%

Mumbai (Maharashtra) [India], November 6: Patil Automation Limited (NSE: PATILAUTOM | INE17GV01016), a leading provider of turnkey welding, assembly and robotics-integrated automation solutions, has released its Unaudited Standalone and Consolidated Financial Results for the half year ended September 30, 2026, reporting broad-based growth across the group. Performance Snapshot – H1 FY27 H1 FY27 Key Financial […]

Read More